Correction for Interference by Test Samples in High-Throughput Assays

In high-throughput biochemical assays performed in multiwell plates, the effect of test samples on the activity of the biochemical system is usually measured by optical means such as absorbance, fluorescence, luminescence, or scintillation counting. The test sample often causes detection interference when it remains in the well during the measurement. Interference may be due to light absorption, fluorescence quenching, sample fluorescence, chemical interaction of the sample with a detection reagent, or depression of the meniscus. A simple method is described that corrects for such interference well by well. The interference is measured in a separate artifact assay plate. An appropriate arithmetic correction is then applied to the measurement in the corresponding well of the activity assay plate. The correction procedure can be used for single-point screening or potency measurements on serial dilutions of test samples.

[1]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[2]  Ruili Huang,et al.  Fluorescence spectroscopic profiling of compound libraries. , 2008, Journal of medicinal chemistry.

[3]  J Fraser Glickman,et al.  Scintillation proximity assays in high-throughput screening. , 2008, Assay and drug development technologies.

[4]  B. Strehler,et al.  Firefly luminescence in the study of energy transfer mechanisms. I. Substrate and enzyme determination. , 1952, Archives of biochemistry and biophysics.

[5]  N. Blomberg,et al.  An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca's drug discovery programmes. , 2007, Current topics in medicinal chemistry.

[6]  Robert W. Bryant,et al.  Evaluation of Fluorescent Compound Interference in 4 Fluorescence Polarization Assays: 2 Kinases, 1 Protease, and 1 Phosphatase , 2003, Journal of biomolecular screening.

[7]  C. Eggeling,et al.  New fluorescence techniques for high-throughput drug discovery. , 2003, Current pharmaceutical biotechnology.

[8]  C. Parker,et al.  Recommendations for the reduction of compound artifacts in time-resolved fluorescence resonance energy transfer assays. , 2007, Assay and drug development technologies.

[9]  Robert Nadon,et al.  An efficient method for the detection and elimination of systematic error in high-throughput screening , 2007, Bioinform..

[10]  K. Itaya,et al.  A new micromethod for the colorimetric determination of inorganic phosphate. , 1966, Clinica chimica acta; international journal of clinical chemistry.

[11]  Christopher P Austin,et al.  Characterization of chemical libraries for luciferase inhibitory activity. , 2008, Journal of medicinal chemistry.

[12]  D. Earnshaw,et al.  Time-Resolved Fluorescence Energy Transfer DNA Helicase Assays for High Throughput Screening , 1999, Journal of biomolecular screening.

[13]  Christopher P Austin,et al.  High-throughput screening assays for the identification of chemical probes. , 2007, Nature chemical biology.